TITLE

AstraZeneca makes vaccines purchase

AUTHOR(S)
Gibson, Jane
PUB. DATE
April 2007
SOURCE
ICIS Chemical Business;4/30/2007, Vol. 2 Issue 64, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the acquisition of U.S. biotechnology firm MedImmune by Astrazeneca. The move by Astrazeneca is aimed at accelerating its biologics strategy and give it access to the vaccines market for the first time. MedImmune's key products include the FluMist nasal spray flu vaccine and the monoclonal antibody Synagis, used to treat infectious respiratory disease. AstraZeneca's first-quarter 2007 sales rose by 9% to $6.97 billion.
ACCESSION #
25073697

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics